(a) Peripheral blood smear in a patient with the chronic phase of chronic myeloid leukemia (CML) before treatment; (b) Detection of BCR::ABL1 fusion gene, p210 by RNA sequencing; (c) Peripheral blood ...
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...
Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...
Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...
Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (Duncan NRI) have created a new way to measure genetic variants in the ...
To permanently access this eBook for free, fill out the short form below. Ready to revolutionise your molecular testing for myeloid malignancies? With a constantly expanding list of biomarkers, ...
News-Medical.Net on MSN
GeneSight test-guided treatment leads to faster remission and response in patients with depression
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...
It has been another stellar week for Genedrive after it revealed signs of commercial traction for its technology, followed by news of potential fresh investment.
Ribosomes are the cell's protein factories, which read the genetic code and assemble the proteins that every organism needs ...
SALT LAKE CITY, Oct. 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2025 earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback